Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$21.81 - $25.14 $1.73 Million - $1.99 Million
79,263 New
79,263 $1.86 Million
Q4 2022

Feb 14, 2023

BUY
$12.64 - $25.52 $746,935 - $1.51 Million
59,093 New
59,093 $1.5 Million
Q2 2022

Aug 15, 2022

SELL
$8.95 - $19.24 $246,133 - $529,119
-27,501 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$11.33 - $19.3 $56,650 - $96,500
-5,000 Reduced 15.38%
27,501 $486,000
Q4 2021

Feb 14, 2022

SELL
$18.0 - $34.82 $104,850 - $202,826
-5,825 Reduced 15.2%
32,501 $592,000
Q3 2021

Nov 15, 2021

BUY
$23.42 - $37.93 $546,294 - $884,755
23,326 Added 155.51%
38,326 $929,000
Q2 2021

Aug 16, 2021

BUY
$26.65 - $39.47 $399,750 - $592,050
15,000 New
15,000 $516,000

Others Institutions Holding OLK

About Olink Holding AB (publ)


  • Ticker OLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 119,098,000
  • Description
  • Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research. Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; and Olink Focus...
More about OLK
Track This Portfolio

Track Cinctive Capital Management LP Portfolio

Follow Cinctive Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cinctive Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Cinctive Capital Management LP with notifications on news.